Trends in breast cancer mortality in Sweden before and after implementation of mammography screening

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Haukka, Jari ^a   Byrnes, Graham ^b   Boniol, Mathieu ^b,c   Autier, Philippe ^b,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SCREENING; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAMMOGRAPHY; MATHEMATICAL MODEL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SEASONAL VARIATION; SURVIVAL RATE; SWEDEN; TREND STUDY; BREAST TUMOR; CLINICAL TRIAL; EARLY DIAGNOSIS; FACTUAL DATABASE; INCIDENCE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; REPRODUCIBILITY; STATISTICS; TIME;

ADULT; AGED; BREAST NEOPLASMS; DATABASES, FACTUAL; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; MORTALITY; REPRODUCIBILITY OF RESULTS; SWEDEN; TIME FACTORS;

EID: 80053157556     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022422     Document Type: Article

References (25)

1. Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjöld B, et al. (2002) Long-term effects of mammography screening: updated overview of the Swedish randomised trials. The Lancet 359: 909-919 doi:10.1016/S0140-6736(02)08020-0.
2. Tabar L, Vitak B, Chen H, Duffy S, Yen M, et al. (2000) The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin North Am 38: 625-651.
3. The Swedish Organised Service Screening Evaluation Group (2006) Reduction in Breast Cancer Mortality from the Organised Service Screening with Mammography: 2. Validation with Alternative Analytic Methods. Cancer Epidemiology Biomarkers & Prevention 15: 52-56 doi:10.1158/1055-9965.EPI-05-0953.
4. Olsen AH, Agbaje OF, Myles JP, Lynge E, Duffy SW, (2006) Overdiagnosis, Sojourn Time, and Sensitivity in the Copenhagen Mammography Screening Program. The Breast Journal 12: 338-342 doi:10.1111/j.1075-122X.2006.00272.x.
5. Zahl P-H, Maehlen J, Welch HG, (2008) The Natural History of Invasive Breast Cancers Detected by Screening Mammography. Arch Intern Med 168: 2311-2316 doi:10.1001/archinte.168.21.2311.
6. Törnberg S, Carstensen B, Hakulinen T, Lenner P, Hatschek T, et al. (1994) Evaluation of the effect on breast cancer mortality of population based mammography screening programmes. J Med Screen 3: 184-187.
7. Jonsson H, Törnberg S, Nyström L, Lenner P, (2000) Service Screening with Mammography in Sweden: Evaluation of Effects of Screening on Breast Cancer Mortality in Age Group 40-49 Years. Acta Oncol 39: 617-623 doi:10.1080/028418600750013302.
8. Jonsson H, Nyström L, Törnberg S, Lenner P, (2001) Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer. J Med Screen 8: 152-160 doi:10.1136/jms.8.3.152.
9. Jonsson H, Törnberg S, Nyström L, Lenner P, (2003) Service screening with mammography of women aged 70-74 years in Sweden: Effects on breast cancer mortality. Cancer Detection and Prevention 27: 360-369 doi:10.1016/S0361-090X(03)00131-4.
10. Jonsson H, Nyström L, Törnberg S, Lundgren B, Lenner P, (2003) Service screening with mammography. Long-term effects on breast cancer mortality in the county of Gävleborg, Sweden. The Breast 12: 183-193 doi:10.1016/S0960-9776(03)00031-6.
11. Lenner P, Jonsson H, (1997) Excess mortality from breast cancer in relation to mammography screening in northern Sweden. 4: 6-9.
12. Tabar L, Yen M-F, Vitak B, Chen H-HT, Smith RA, et al. (2003) Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. The Lancet 361: 1405-1410 doi:10.1016/S0140-6736(03)13143-1.
13. The Swedish Organised Service Screening Evaluation Group (2006) Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data. Cancer Epidemiol Biomarkers Prev 15: 45-51.
14. The Swedish Organised Service Screening Evaluation Group (2006) Reduction in Breast Cancer Mortality from Organized Service Screening with Mammography: 1. Further Confirmation with Extended Data. Cancer Epidemiology Biomarkers & Prevention 15: 45-51 doi:10.1158/1055-9965.EPI-05-0349.
15. Engholm G, Ferlay J, Christensen N, Bray F, Ólafsdóttir E, et al. (2010) NORDCAN: Cancer Incidence, Mortality and Prevalence in the Nordic Countries. Acta Oncol 49: 725-36.
16. von Karsa L, Anttila A, Ronco G, (2008) Cancer Screening in the European UnionReport on the implementation of the Council Recommendation on cancer screening. First Report Luxembourg European Comission p. Available: http://ec.europa.eu/health/ph_determinants/genetics/documents/cancer_screening.pdf.
17. Shwartz M, (1980) Estimates of lead time and length bias in a breast cancer screening program. Cancer 46: 844-851 doi:10.1002/1097-0142(19800815)46:4&844::AID-CNCR2820460434>3.0.CO;2-5.
18. Hery C, Ferlay J, Boniol M, Autier P, (2008) Changes in breast cancer incidence and mortality in middle-aged and elderly women in 28 countries with Caucasian majority populations. Ann Oncol 19: 1009-1018.
19. Zahl P-H, Jørgensen KJ, Mæhlen J, Gøtzsche PC, (2008) Biases in estimates of overdetection due to mammography screening. Lancet Oncol 9: 189-201.
20. Biesheuvel C, Barratt A, Howard K, Houssami N, Irwig L, (2007) Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review. The Lancet Oncology 8: 1129-1138 doi:10.1016/S1470-2045(07)70380-7.
21. Morrell S, Barratt A, Irwig L, Howard K, Biesheuvel C, et al. (2010) Estimates of overdiagnosis of invasive breast cancer associated with screening mammography. Cancer Causes Control 21: 275-282 doi:10.1007/s10552-009-9459-z.
22. Duffy SW, Lynge E, Jonsson H, Ayyaz S, Olsen AH, (2008) Complexities in the estimation of overdiagnosis in breast cancer screening. Br J Cancer 99: 1176-1178.
23. Jørgensen KJ, Gøtzsche PC, (2009) Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ 339 doi:10.1136/bmj.b2587.
24. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, et al. (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353: 1784-1792 doi:10.1056/NEJMoa050518.
25. Autier P, Boniol M, LaVecchia C, Vatten L, Gavin A, et al. (2010) Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ 341 doi:10.1136/bmj.c3620.